Eμ-Myc HPCs with Pim2: pre-B-cell lymphomas with 100% incidence at 10.7 weeks of age. Resistant to doxorubicin, rapamycin, and combination treatment. The gene discussed is PIM2; the disease is B-cell non-Hodgkin lymphoma.